Table 4.
Univariate logistic regression associated with vascular invasion after PSM
| Risks | Univariate analysis | |
|---|---|---|
| OR (95% CI) | P | |
| Age, n (%) | ||
| ≤ 60 | Reference | |
| > 60 | 0.36 (0.15, 0.87) | 0.015 |
| Sex, n (%) | ||
| Female | Reference | |
| Male | 1.58 (0.6, 4.2) | 0.342 |
| Albumin, n (%) | ||
| ≤ 40 | Reference | |
| > 40 | 1.37 (0.74, 2.56) | 0.315 |
| TB, n (%) | ||
| ≤ 20 | Reference | |
| > 20 | 1.6 (0.5, 5.12) | 0.417 |
| AFP, n (%) | ||
| ≤ 400 | Reference | |
| > 400 | 2.11 (1.08, 4.12) | 0.029 |
| Cirrhosis, n (%) | ||
| No | Reference | |
| Yes | 0.93 (0.42, 2.08) | 0.864 |
| Size, n (%) | ||
| ≤ 5 | Reference | |
| > 5 | 2.68 (1.42, 5.07) | 0.002 |
| Number, n (%) | ||
| Solitary | Reference | |
| Multiple | 1.24 (0.6, 2.55) | 0.567 |
| Tumor capsule, n (%) | ||
| Absence | Reference | |
| Presence | 2.05 (1.09, 3.87) | 0.026 |
| Differential, n (%) | ||
| Good | Reference | |
| Moderate/poor | 4.71 (2.42, 9.17) | < 0.001 |
| BCLC, n (%) | ||
| A | Reference | |
| B | 2.61 (1.32, 5.15) | 0.006 |
| C | 2.88 (2.18, 3.42) | < 0.001 |
| ALBI Grade, n (%) | ||
| A | Reference | |
| B | 1.27 (0.65, 2.46) | 0.485 |
| GGT/ALT | ||
| ≤ 2.95 | Reference | |
| > 2.95 | 1.86 (1.23, 3.33) | 0.037 |
TB, Total Bilirubin; AFP, α-fetoprotein; BCLC, Barcelona Clinic Liver Cancer staging; ALBI grade, Albumin-Bilirubin Grade; GGT, γ-Glutamyl Transpeptidase; ALT, Alanine aminotransferase